Great Toe Implant System
510(k) K014164
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK014164 | Date12 Mar 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KWD
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3730
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Great Toe Implant System is a prosthesis for the toe, specifically a hemi-phalangeal implant, classified as a Class II medical device under FDA regulation 888.3730. It is intended for use in the treatment of patients with inflammatory arthritis in the first metatarsal joint, particularly in cases with good bone stock and integrity of the first metatarsal head, and is indicated for conditions including hallux valgus, hallux rigidus, and an unstable or painful metatarsophalangeal (MTP) joint.
The device was cleared by the FDA through the traditional 510(k) pathway under K014164, with a decision date of March 12, 2002, and is substantially equivalent to predicate devices. It is manufactured by Harmos Orthopaedics, Inc., and is supplied as a single-use implant system for orthopedic surgical procedures, with no indication of reusability or MRI safety provided in the data.
Questions
AI-generated answers, 24 Sep 2026
What is the Great Toe Implant System used for?
The Great Toe Implant System is a hemi-phalangeal prosthesis intended for treating patients with inflammatory arthritis in the first metatarsal joint, particularly when there is good bone stock and integrity of the first metatarsal head, and is indicated for conditions including hallux valgus, hallux rigidus, and an unstable or painful metatarsophalangeal (MTP) joint.
How is the Great Toe Implant System supplied and is it reusable?
The device is supplied as a single-use implant system for orthopedic surgical procedures, with no indication of reusability provided in the data, meaning it is intended for one-time use only and should not be reprocessed or reused.
What regulatory pathway was used for the Great Toe Implant System?
The Great Toe Implant System was cleared by the FDA through the traditional 510(k) pathway under K014164, with a decision date of March 12, 2002, and is substantially equivalent to predicate devices.